SUMMARY -Muscle pain occurs in various neuromuscular disorders with characteristic physiological or biochemical abnormalities. There is, however, a group of patients in whom there is no clear physiological or structural basis for their pains. This syndrome has been called fibrositis or fibromyalgia. Sleep abnormalities have been reported in some of these patients, but have not been confirmed by others. We studied 8 patients with this disorder and found sleep abnormalities that were characterized by nocturnal myoclonus, alpha-delta sleep, and abnormalities compatible with depression. Polysomnography was, therefore, instrumental in helping direct the treatment of these patients. Therapeutic approaches aimed to correct the specific disorders were effective in improving the pain symptoms
PATIENTS AND METHODS
We studied 8 patients with chronic muscle pains and fatigue who had a history of trigger points that fulfill the criteria of Moldofsky and Lue 17 for «fibrositis». The sex, age, and pain duration for these eight patients are summarized in Table 1 . All patients were studied clinically by ischemic exercise tests, by muscle biopsy for biochemistry and biochemical tests, and by electromyography. All tests were negative, and the etiology for muscle pains in these patients could not be demonstrated.
All of these subjects were submitted to polysomnography for 1 or 2 nights at their regular bedtimes and for the duration of their average sleep in the circadian cycle. Polysomnography comprised EEG activity, recorded by C3-A2 and A4-A2 scalp electrodes, eye movement recorded by right eye to frontal pole and frontal pole to left eye electrodes. Muscle activity was recorded by chin and leg electrodes. Respirations were monitored by nasal and buccal thermistors and by chest and abdominal strain gauges. EKG activity was recorded by two chestelectrodes. Stage Rapid Eye Movement (REM) latency in this study was measured from stage 2 2. All patients were monitored by video camera with infrared illumination and microphones. The room temperature setting was 73^F.
The records were scored according to standard criteria 22. Data from these individuals were compared with those from normal patients previously studied in our laboratory. With one exception, all 8 patients under study also had psychiatric surveys and responded to Beck's Inventory for depression. Results of polysomnography and psychiatric evaluation on the patient population studied are shown in Table 2 .
The decision to treat patients with clonazepam, amitriptyline, and alprazolam, was based upon the clinical diagnosis and psychiatric condition, aided by PSG. The degree of improvement in fibrositis symptoms and response to therapy were established as follows: no improvement; minimal improvement; mild improvement; moderate improvement; significant improvement; and disappearance of symptoms. Table 2 , psychiatric interviews revealed signs of both anxiety and depression in two patients (patients 2 and 7). Depression was documented during psyschiatric interview in three patients (patients 3, 6, and 8). Beck's Inventory revealed high scores for depression in patients 2, 4, and 6. Four individuals showed REM sleep latency less than 70 minutes, which is consistent with depression 5,8,15. It is to be noted that depression in two of these subjects was not detected by psychiatric interview or by Beck's depression inventory. Other causes for short REM latency, such as narcolepsy, schedule disorders, and effect of drugs or alcohol, were excluded in all cases. Alpha-delta activity was present in only two patients; four subjects exhibited nocturnal myoclonus. Neither parameter appeared to correlate with psychiatric results.
RESULTS

As shown in
Responses to therapy in these patients are summarized in Table 3 . Except for one patient whose follow-up was lost, some degree of improvement in symptoms of fibrositis was noted in all patients. Significant improvement or disappearance of symptoms was noted in three subjects and mild to moderate improvement in the remainder.
COMMENTS
Patients with muscle pains are often a challenge to neuromuscular specialists and neurologists, and when these are not explained by standard diagnostic tests for metabolic physiological or structural muscle diseases, the management could be rather frustrating.
The patients studied belong to such group, with unexplained muscle pain and the characteristic of «fibrositis» syndrome 3,4. Although our population was somewhat unusual because of its male predominance 8, it fulfilled the diagnostic criteria outlined by others 17.
Reported studies of muscle biopsy mainly show nonspecific findings and type II fiber atrophy 13,14 with somewhat abnormal oxidative enzyme staining, muscle necrosis, and subsarcolemmal accumulation of mitochondria U-13. The abnormalities are by no means specific.
Because the diagnosis of «fibrositis» is based on clinical findings, groups of patients in previous studies have not always been similar. In some studies, all patients with unexplained muscle pains were included. In others, strict clinical criteria were used to define the study population 17. Even when strict criteria were applied, however, the groups have not been homogenous. Some investigators have reported a high incidence of depression 1,7,12,2^ while others have separated «fibrositis» patients from those with depression-induced muscle pain 9.25. The present study demonstrates that such separation is artificial, based on the high incidence of depression in patients with classical fibrositis.
In agreement with Moldofsky and colleagues 1^ we have found that sleep abnormalities are common in the «fibrositis» syndrome. These authors considered that alpha-delta sleep patterns characterize this syndrome. However, in our patient population, the alpha-delta sleep pattern was only present in two patients.
We also found that nocturnal myoclonus was present in half of our patients. Moldofsky et al. 20 found similar abnormalities in their older population, suggesting that there is a group of «fibrositis» patients in which these, rather than the alpha-delta sleep is more characteristic.
It is conceivable that nocturnal myoclonus precedes the alpha-delta sleep pattern and that our patients would acquire abnormalities later. However, nocturnal myoclonus could, by itself, trigger muscle pains and fatigue, as occurred in our patients; these individuals did improve with therapy aimed to suppress myoclonus.
We cannot determine if depression was a consequence or the cause of muscle pains, but the finding by others of alpha-delta sleep pattern in patients with rheumatoid arthritis 18 and post-traumatic pains 24 suggest that painful conditions can produce this sleep abnormality, which leads to more muscle pains, thereby creating a vicious cycle.
Our studies indicate that polysomnography appears to have importance in the evaluation of patients with unexplained muscle pains which often present to neuromuscular clinics and can aid in the determination of therapeutic intervention by demonstrating leg myoclonus in some patients, as in 50% of our cases, or aiding and reaffirming the diagnosis of depression in others by snowing short REM latency, also true of 50% of our patients.
While the number of patients in this study is relatively small, it represents a unique group of individuals fitting the diagnosis of fibrositis and who were thoroughly evaluated by neurological means; by muscular pathology, including muscle biopsy and pyschiatric evaluation; and by polysomnography. Except for chronic pain, as a group these patients did not show another diagnostic finding clearly defining the syndrome ( Table 2) . Specifically, while 50% of the patients displayed leg myoclonus in their sleep, only two had documented alpha-delta sleep, pointing to the nonspecificity of this finding in the disorder. On the other hand, clinical psychiatric evaluation and polysomnography profile pointed to a diagnosis of anxiety, depression, or both. Also, 50% of the patients demonstrated leg myoclonus during the PSG, which helped the physicians to direct the treatment, with some success. We recognize the need for studies of additional cases in order to firmly establish the diagnostic criteria for this condition. The findings in this study, however, permitted more defined therapeutic managment, with overall improvement in 7 patients; one additional patient was lost to follow-up.
